Myriad Genetics Inc (MYGN)
15.12
-0.18
(-1.14%)
USD |
NASDAQ |
Nov 21, 16:00
15.12
0.00 (0.00%)
After-Hours: 18:30
Myriad Genetics Price to Book Value: 1.882 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 1.904 |
| November 19, 2024 | 1.866 |
| November 18, 2024 | 1.894 |
| November 15, 2024 | 1.897 |
| November 14, 2024 | 1.951 |
| November 13, 2024 | 1.963 |
| November 12, 2024 | 2.012 |
| November 11, 2024 | 2.154 |
| November 08, 2024 | 2.166 |
| November 07, 2024 | 2.198 |
| November 06, 2024 | 2.186 |
| November 05, 2024 | 2.191 |
| November 04, 2024 | 2.218 |
| November 01, 2024 | 2.237 |
| October 31, 2024 | 2.731 |
| October 30, 2024 | 2.832 |
| October 29, 2024 | 2.770 |
| October 28, 2024 | 2.731 |
| October 25, 2024 | 2.681 |
| October 24, 2024 | 2.712 |
| October 23, 2024 | 2.776 |
| October 22, 2024 | 2.813 |
| October 21, 2024 | 2.803 |
| October 18, 2024 | 2.909 |
| October 17, 2024 | 2.902 |
| Date | Value |
|---|---|
| October 16, 2024 | 2.975 |
| October 15, 2024 | 2.982 |
| October 14, 2024 | 3.122 |
| October 11, 2024 | 2.995 |
| October 10, 2024 | 2.869 |
| October 09, 2024 | 3.031 |
| October 08, 2024 | 3.229 |
| October 07, 2024 | 3.251 |
| October 04, 2024 | 3.292 |
| October 03, 2024 | 3.287 |
| October 02, 2024 | 3.353 |
| October 01, 2024 | 3.362 |
| September 30, 2024 | 3.406 |
| September 27, 2024 | 3.245 |
| September 26, 2024 | 3.217 |
| September 25, 2024 | 3.200 |
| September 24, 2024 | 3.256 |
| September 23, 2024 | 3.303 |
| September 20, 2024 | 3.39 |
| September 19, 2024 | 3.470 |
| September 18, 2024 | 3.492 |
| September 17, 2024 | 3.508 |
| September 16, 2024 | 3.422 |
| September 13, 2024 | 3.384 |
| September 12, 2024 | 3.237 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6768
Minimum
Mar 18 2020
3.508
Maximum
Sep 17 2024
2.077
Average
2.095
Median
Mar 25 2022
Price to Book Value Benchmarks
| Boston Scientific Corp | 6.512 |
| ResMed Inc | 6.884 |
| Globus Medical Inc | 2.840 |
| Perspective Therapeutics Inc | 0.6153 |
| Electromed Inc | 5.682 |
Price to Book Value Related Metrics
| PS Ratio | 1.643 |
| Price | 15.12 |
| Earnings Yield | -8.60% |
| Market Cap | 1.377B |